Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
Explainer-Who in the US benefits from $35 insulin?
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
The Indianapolis Star7 天
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi. Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply. Novo Nordisk ...
Business Wire22 小时
ADOCIA Reports Third Quarter 2024 Financial Results and Provides a Business Update
The PACEO, established in March 2024, is a controlled financing solution pending revenues from BioChaperone Lispro and the ...
The Indianapolis Star6 天
As insulin shortages persist, what diabetes patients can do
Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter ... reported shortages of NovoLog insulin. Drug companies recommend patients check with ...